跳至主要内容
临床试验/ISRCTN99451262
ISRCTN99451262进行中(未招募)Unknown

Genetic screening in Parkinson’s disease patients to identify GBA1 mutation carriers for future clinical trials

Vanqua Bio Inc.0 个研究点目标入组 1,000 人开始时间: 2023年11月8日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Age 40-80
  • 2. All participants must understand and provide written informed consent prior to any study-specific procedures
  • 3. Able to speak, read, and understand study procedures in Dutch sufficiently to allow completion of all study assessments
  • 4. Confirmed clinical diagnosis of Parkinson’s disease by a neurologist within the last 5 years, based on presence of bradykinesia and either resting tremor and/or muscular rigidity in at least one limb
  • 5. Willing to be contacted regarding potential participation in future interventional clinical trials

排除标准

  • 1. History of a significant medical or psychiatric comorbidity that would preclude the subject’s participation in an interventional clinical trial
  • 2. Known GBA-1 mutation for Parkinson’s disease

研究者

发起方
Vanqua Bio Inc.

相似试验